Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Boen L. R. Kam

Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2016English

Peptide Receptor Radionuclide Therapy in Patients With Medullary Thyroid Carcinoma: Predictors and Pitfalls

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Related publications

Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Maintaining Radiochemical Purity of [177Lu]Lu-Dota-Psma-617 for PRRT by Reducing Radiolysis

Journal of Radioanalytical and Nuclear Chemistry
Nuclear MedicineRadiologyMutagenesisNuclear EnergyPublic HealthAnalytical ChemistryEnvironmentalEngineeringHealthImagingSpectroscopyToxicologyOccupational HealthPollution
2019English

Effects of Therapy With [177Lu-DOTA0,Tyr3]octreotate on Endocrine Function

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors With [177Lu-DOTA0,Tyr3]Octreotate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Rapid Kit-Based 68Ga-Labelling and PET Imaging With THP-Tyr3-octreotate: A Preliminary Comparison With DOTA-Tyr3-octreotate

EJNMMI Research
Nuclear MedicineRadiologyImaging
2015English

Pitfalls in the Response Evaluation After Peptide Receptor Radionuclide Therapy With [ 177 Lu-Dota 0 ,Tyr 3 ]Octreotate

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

[177Lu]-Dota0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2010English

Potential Biomarkers for Radiation-Induced Renal Toxicity Following 177Lu-Octreotate Administration in Mice

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy